Tag Archives: ARWR
What Did This CEO Just Do with Personal Shares of Arrowhead Research (NASDAQ: ARWR)?
Today, the CEO of Arrowhead Research (ARWR – Research Report), Christopher Richard Anzalone, sold shares of ARWR for $965K. Following Christopher Richard Anzalone’s last ARWR Sell transaction on July 05, 2016, the stock climbed by 14.6%. This is Anzalone’s first
A Director at Arrowhead Research (NASDAQ: ARWR) is Selling Shares
Yesterday, a Director at Arrowhead Research (ARWR – Research Report), Douglas Given, sold shares of ARWR for $1.25M. Following Douglas Given’s last ARWR Sell transaction on August 19, 2014, the stock climbed by 4.9%. See today’s analyst top recommended stocks
Arrowhead Research (ARWR) Gets a Buy Rating from Chardan Capital
Chardan Capital analyst Keay Nakae reiterated a Buy rating on Arrowhead Research (ARWR – Research Report) on February 8 and set a price target of $24.50. The company’s shares closed on Friday at $15.66. According to TipRanks.com, Nakae is currently
B.Riley FBR Remains a Buy on Arrowhead Research (ARWR)
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Arrowhead Research (ARWR – Research Report) today and set a price target of $19. The company’s shares closed on Friday at $15.66. Mamtani said: “Inc (ARWR) reported fiscal 1Q19 (calendar
Friday’s Midday Stock Update: Arrowhead Research (ARWR), Celldex (CLDX), Electronic Arts (EA), OHR Pharmaceutical (OHRP), Pixelworks (PXLW)
So far Friday, February 8, NASDAQ is up 1.08% and the S&P is down -0.23%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Arrowhead Research (ARWR – Research Report), Celldex (CLDX – Research
Friday’s Highlights at Noon: Arrowhead Research (ARWR), Celldex (CLDX), Nuverra Environmental Solutions, Inc. (NES), Electronic Arts (EA), Pixelworks (PXLW)
So far Friday, February 8, NASDAQ is up 0.84% and the S&P is down -0.32%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Arrowhead Research (ARWR – Research Report), Celldex (CLDX – Research
